Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00596635 · ClinicalTrials.gov registry record · NA
Cranberry for UTI Prevention in Residents of Long Term Care Facilities
A NA study, sponsored by Yale University.
- Completed
- Registry status
- NA
- Development phase
- 56
- Enrollment target
NCT00596635 is a NA study that has completed, run by Yale University. The registered enrollment target is 56 participants.
The verdict
NCT00596635, a NA study, has completed, sponsored by Yale University.
- COMPLETED
- Registry status
- NA
- Development phase
- 56 participants
- Enrollment target
Study Summary
Urinary tract infections (UTIs) affect over 7 million men and women per year and cost the health care industry over 1 billion dollars annually. The incidence of UTI increases markedly in elderly institutionalized persons and leads to excessive antimicrobial usage, emergency room visits, hospitalization, sepsis, and death. The use of antimicrobials to prevent UTI in elderly nursing home patients is not recommended and is fraught with problems such as adverse reactions, drug interactions, and the development of drug-resistant organisms. There is no accepted method of preventing UTI in residents of nursing homes, a vulnerable and understudied population with significant morbidity from UTI. The overall goal of this proposal is to conduct a prospective cohort pilot study that evaluates the feasibility of using cranberry to prevent UTI in nursing home residents. Each of the aims is critical for the optimal design of a larger placebo-controlled, definitive trial of cranberry for prevention of UTI in nursing home residents and will provide the essential preliminary data for future larger studies.
Interventions
- DIETARY_SUPPLEMENT Once Daily Cranberry Capsule
- DIETARY_SUPPLEMENT Twice Daily Cranberry Capsules
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 56 participants |
| Start Date | 2007-01 |
| Est. Completion | 2008-08 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00596635
The ClinicalTrials.gov registry entry for NCT00596635 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 56 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Yale University, which has 1,492 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Once Daily Cranberry Capsule is the first listed.
NCT00596635 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00596635 about?
NCT00596635 is a clinical study titled "Cranberry for UTI Prevention in Residents of Long Term Care Facilities". Urinary tract infections (UTIs) affect over 7 million men and women per year and cost the health care industry over 1 billion dollars annually. The incidence of UTI increases markedly in elderly institutionalized persons and leads to excessive antimicrobial usage, emergency room visits, hospitalizat...
What is the current status of trial NCT00596635?
This trial is currently completed. It is a NA study. The enrollment target is 56 participants. The study started on 2007-01. Estimated completion is 2008-08.
What interventions are being tested in trial NCT00596635?
The interventions under investigation include: Once Daily Cranberry Capsule (DIETARY_SUPPLEMENT), Twice Daily Cranberry Capsules (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT00596635?
This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.